Halotestin

Fluoxymesterone — Halotestin by Dragon Pharma

Halotestin is Dragon Pharma's formulation of oral Fluoxymesterone at 10mg per tablet — one of the most androgenically potent oral steroids ever developed, with an androgenic ratio of approximately 1,600 versus testosterone's baseline of 100. Unlike most mass-building oral steroids, Halotestin produces minimal weight gain while delivering exceptional strength and aggression enhancement, making it used almost exclusively as a pre-competition or pre-event compound.

Also searched as: Fluoxymesterone 10mg, Halotestin tabs, Halo steroid, Halotestin Dragon Pharma.

What Is Fluoxymesterone (Halotestin)?

Fluoxymesterone is a 17-alpha-methylated synthetic testosterone derivative developed by Upjohn in the 1950s. Originally approved for several medical indications including hypogonadism, delayed puberty and — critically — the treatment of breast cancer in postmenopausal women, reflecting its potent anti-estrogenic environment despite being an androgen. In athletic use, Halotestin's primary value is neurological: it does not build meaningful mass, but produces acute strength and aggression enhancement used in the final days before powerlifting competition or combat sports events.

Why Halotestin Does Not Aromatise — Despite Testosterone-Like Structure

A genuine information gap: Fluoxymesterone is structurally derived from testosterone but does not aromatise — a non-obvious fact given its structural similarity:

• Testosterone aromatises because the aromatase enzyme converts its A-ring structure — specifically, it removes the C-19 methyl group and creates the characteristic aromatic A-ring of estrogen
• Fluoxymesterone has two fluorine substitutions (at C-9 and the 11-beta hydroxyl group) that prevent the aromatase enzyme from processing the A-ring — the fluorine atoms effectively block the enzymatic reaction required for conversion
• This means Fluoxymesterone produces no estrogen conversion, no water retention and no gynecomastia from the compound itself — while still being an extremely potent androgen
• The historical use in breast cancer treatment makes chemical sense: an extremely potent androgen that doesn't convert to estrogen can suppress estrogen-driven cancer cell proliferation in a high-androgen environment without adding estrogenic fuel

The Neurobiological Mechanism Behind Halotestin's Aggression Effect

Halotestin's aggression effect is regularly described as a "side effect" in competitor content — rarely explained mechanistically:

• Fluoxymesterone and its metabolites interact with GABA-A receptors in the central nervous system — the same receptor family targeted by anxiolytics and alcohol
• Specifically, androgenic metabolites of Fluoxymesterone act as neuroactive steroids (neurosteroids) that modulate GABA-A receptor subunit composition and sensitivity in brain regions governing aggression, confidence and competitive drive
• This neurosteroid activity is distinct from the peripheral androgenic effects — it operates at the CNS level, producing the characteristic psychological state of elevated competitive drive, reduced fear response and increased willingness to push through pain that Halotestin users describe
• This is why Halotestin's aggression effect is qualitatively different from simply "elevated androgens" — it is a direct neurological action, not just a peripheral hormonal effect that filters through the CNS

Halotestin vs Other Pre-Event Strength Compounds

Effects and Benefits

• Exceptional acute strength increases — consistently cited as one of the most pronounced strength-to-mass ratio effects of any oral steroid
• Significant aggression and competitive drive enhancement through direct neurosteroid CNS activity
• No aromatisation — no water retention or estrogenic effects
• Dry, hard appearance — minimal weight gain makes it useful in weight-class sports where staying within a weight category is essential
• Increased red blood cell production — documented haematological effect that improves oxygen delivery and training endurance

Dosage and Administration

With an ~9-hour half-life, Halotestin is typically taken once or twice daily. Due to its severe hepatotoxicity — among the highest of any oral steroid — cycle length is strictly limited to 2-4 weeks with liver enzyme monitoring before and after. Most powerlifters and strength athletes restrict use to the final 2-4 weeks of contest preparation or use a single dose on competition day.